PURPOSE: Farnesyltransferase (FTase) is a zinc-dependent enzyme that adds a farnesyl group to the Ras proteins. L778, 123 is a potent peptidomimetic imidazole-containing FTase inhibitor. METHODS: L778123 was synthesized according to known methods and evaluated alone and in combination with doxorubicin against A549 (adenocarcinomic human alveolar basal epithelial cells) and HT29 (human colonic adenocarcinoma) cell lines by MTT assay. RESULTS: L778123 showed weak cytotoxic activity with IC50 of 100 and 125 for A549 and HT-29 cell lines, respectively. The combination of doxorubicin and L778123 can decrease IC50 of doxorubicin in both cell lines significantly. CONCLUSION: It can be concluded that L778, 123 can be a good agent for combination therapy.
PURPOSE: Farnesyltransferase (FTase) is a zinc-dependent enzyme that adds a farnesyl group to the Ras proteins. L778, 123 is a potent peptidomimetic imidazole-containing FTase inhibitor. METHODS:L778123 was synthesized according to known methods and evaluated alone and in combination with doxorubicin against A549 (adenocarcinomic human alveolar basal epithelial cells) and HT29 (humancolonic adenocarcinoma) cell lines by MTT assay. RESULTS:L778123 showed weak cytotoxic activity with IC50 of 100 and 125 for A549 and HT-29 cell lines, respectively. The combination of doxorubicin and L778123 can decrease IC50 of doxorubicin in both cell lines significantly. CONCLUSION: It can be concluded that L778, 123 can be a good agent for combination therapy.
Authors: Patrick Angibaud; Laurence Mevellec; Christophe Meyer; Xavier Bourdrez; Patricia Lezouret; Isabelle Pilatte; Virginie Poncelet; Bruno Roux; Sophie Merillon; David W End; Jacky Van Dun; Walter Wouters; Marc Venet Journal: Eur J Med Chem Date: 2007-01-09 Impact factor: 6.514